HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 202 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2023. The put-call ratio across all filers is 0.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,182,997 | -6.9% | 36,100 | 0.0% | 0.06% | +33.3% |
| Q2 2023 | $1,270,359 | +7.8% | 36,100 | 0.0% | 0.05% | +9.1% |
| Q1 2023 | $1,178,665 | -32.7% | 36,100 | +13.5% | 0.04% | -27.9% |
| Q4 2022 | $1,752,180 | +38.8% | 31,800 | +11.6% | 0.06% | +22.0% |
| Q3 2022 | $1,262,000 | -97.8% | 28,500 | -89.1% | 0.05% | -95.1% |
| Q2 2022 | $57,631,000 | +3734.4% | 261,693 | +746.9% | 1.01% | +2008.3% |
| Q1 2022 | $1,503,000 | +14.0% | 30,900 | 0.0% | 0.05% | +11.6% |
| Q4 2021 | $1,318,000 | +11.3% | 30,900 | 0.0% | 0.04% | +13.2% |
| Q3 2021 | $1,184,000 | +35.8% | 30,900 | 0.0% | 0.04% | +35.7% |
| Q2 2021 | $872,000 | – | 30,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $366,268,777 | 96.46% |
| venBio Partners LLC | 1,035,396 | $33,805,679 | 18.74% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,036,912 | 8.19% |
| Vivo Capital, LLC | 2,606,247 | $85,093,965 | 5.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $18,621,120 | 5.20% |
| ASHFORD CAPITAL MANAGEMENT INC | 445,418 | $14,542,898 | 2.18% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 678,715 | $22,160,045 | 2.07% |
| TANG CAPITAL MANAGEMENT LLC | 321,200 | $10,487,180 | 1.56% |
| AlphaCentric Advisors LLC | 67,500 | $2,203,875 | 1.52% |
| Paradiem, LLC | 66,995 | $2,187,387 | 0.68% |